Publications by authors named "Christine Chevreau"

100Publications

Correction to: Elbow flexion reconstruction after arm-sparing excision for high-grade triton sarcoma: a case report.

J Med Case Rep 2020 08 7;14(1):125. Epub 2020 Aug 7.

Department of Plastic surgery, University Toulouse III Paul Sabatier, Toulouse, France.

View Article and Find Full Text PDF
August 2020

Elbow flexion reconstruction after arm-sparing excision for high-grade triton sarcoma: a case report.

J Med Case Rep 2020 Jul 4;14(1):103. Epub 2020 Jul 4.

Department of Plastic surgery, University Toulouse III Paul Sabatier, Toulouse, France.

View Article and Find Full Text PDF
July 2020

Brain metastases from germ cell tumor: time to reconsider radiotherapy?

Crit Rev Oncol Hematol 2020 Jun 16;150:102946. Epub 2020 Apr 16.

Department of Medical Oncology, Institut Claudius Regaud / Institut Universitaire du Cancer de Toulouse - Oncopole, 1 avenue Irène Joliot-Curie, 31000, Toulouse, France. Electronic address:

View Article and Find Full Text PDF
June 2020

Association between clinically relevant toxicities of pazopanib and sunitinib and the use of weak CYP3A4 and P-gp inhibitors.

Eur J Clin Pharmacol 2020 Apr 13;76(4):579-587. Epub 2020 Jan 13.

Pharmacy department IUCT (Institut Universitaire du Cancer) Oncopole, Institut Claudius Regaud, 1 avenue Irène Joliot-Curie, Toulouse CEDEX 9, 31059, France.

View Article and Find Full Text PDF
April 2020

Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance.

Cancer Chemother Pharmacol 2020 03 9;85(3):585-592. Epub 2020 Jan 9.

Centre de Recherches en Cancérologie de Toulouse (CRCT), INSERM UMR1037, 2 Avenue Hubert Curien, CS53717, 31037, Toulouse CEDEX 1, France.

View Article and Find Full Text PDF
March 2020

PARP1 expression in soft tissue sarcomas is a poor-prognosis factor and a new potential therapeutic target.

Mol Oncol 2019 07 7;13(7):1577-1588. Epub 2019 Jun 7.

Predictive Oncology Laboratory, Marseille Cancer Research Center (CRCM), Institut Paoli-Calmettes, U1068 INSERM, U7258 CNRS, Aix-Marseille University, Marseille, France.

View Article and Find Full Text PDF
July 2019

Efficacy and safety of regorafenib compared to placebo and to post-cross-over regorafenib in advanced non-adipocytic soft tissue sarcoma.

Eur J Cancer 2018 08 11;99:28-36. Epub 2018 Jun 11.

Department of Clinical Research and Innovation, Centre Oscar Lambret, 3 rue Combemale, 59000 Lille, France; Paris-Saclay University, Univ. Paris-Sud, CESP, INSERM, Gustave Roussy, 94805 Villejuif, France. Electronic address:

View Article and Find Full Text PDF
August 2018

Sunitinib Alone or after Nephrectomy in Metastatic Renal-Cell Carcinoma.

N Engl J Med 2018 Aug 3;379(5):417-427. Epub 2018 Jun 3.

From the Departments of Urology (A.M., M.-O.T.) and Medical Oncology (S.O.), Hôpital Européen Georges-Pompidou, Assistance Publique-Hôpitaux de Paris (AP-HP), Université Paris-Descartes, and Paris Descartes Necker-Cochin Clinical Research Unit, AP-HP (S.C.), Paris, the Department of Medical Oncology, Bordeaux University Hospital (A.R.), the Department of Medical Oncology, Hôpital Saint André, Centre Hospitalier Universitaire (CHU) de Bordeaux (M.G.-G.), and the Department of Urology, CHU de Bordeaux and Université de Bordeaux (J.-C.B.), Bordeaux, Biometrics Unit, Cancer Institute of Montpellier, University of Montpellier, Montpellier (S.T.), the Department of Urology, CHU Rangueil (J.-B.B.), and the Department of Medical Oncology, Institut Universitaire du Cancer Toulouse-Oncopole (C.C.), Toulouse, the Department of Urology, University of Rennes (K.B.), and the Department of Medical Oncology, Centre Eugene Marquis (B.L.), Rennes, the Department of Medical Oncology, Institut de Cancerologie de Lorraine, Vandoeuvre lès Nancy (L. Geoffrois), the Department of Medical Oncology, CHU Besançon, Oncologie, and Université de Franche-Comte, INSERM Unité Mixte de Recherche (UMR) 1098, Structure Fédérative de Recherche Ingénierie et Biologie Cellulaire et Tissulaire, Besançon (A.T.-V.), the Department of Urology, CHU François Mitterrand, Dijon (L.C.), the Department of Urology, CHU Strasbourg, Translational Medicine Federation Strasbourg, Strasbourg (H.L.), the Department of Urology, Gabriel Montpied Hospital, and Clermont Auvergne University, Clermont-Ferrand (L. Guy), the Department of Medical Oncology, Centre de Recherche en Cancerologie de Marseille, INSERM UMR 1068, Centre National de la Recherche Scientifique UMR 7258 and Institut Paoli-Calmettes (G.G.), and the Department of Urology, Hôpital la Conception (E.L.), Aix Marseille Université, Marseille, the Department of Medical Oncology, Institut de Cancerologie de l'Ouest, Nantes (F.R.), the Department of Medical Oncology, CHU Bretonneau, and the Department of Medicine, Université François Rabelais, Tours (C.L.), the Department of Urology, Mont de Marsan General Hospital, Mont de Marsan (J.-J.P.), the Departments of Medical Oncology (C.T.) and Urology (T.L.), Hôpital Foch, Suresnes, the Department of Urology, Imagerie Adaptative Diagnostique et Interventionnelle INSERM Unité 1254, CHU de Nancy, Brabois (J.H.), the Department of Medical Oncology, Institut Gustave Roussy and Université Paris-Saclay, Villejuif (L.A., B.E.), and Université Versailles, St.-Quentin-en-Yvelines (T.L.) - all in France; the Department of Urology, Haukeland University Hospital (C.B.), and the Department of Clinical Medicine, University of Bergen (C.B.), Bergen, Norway; and the Department of Urology, Royal Free Hospital, London (M.A.).

View Article and Find Full Text PDF
August 2018

Impact of Trabectedin Interruption and Subsequent Rechallenge on Progression in Patients With Advanced Soft Tissue Sarcoma: Long-term Follow-up of the T-DIS trial.

Am J Clin Oncol 2018 Nov;41(11):1094-1100

*Medical Oncology Department ‡Methodology and Biostatistics Unit #Clinical Research Unit, Centre Oscar Lambret ∥Medical Oncology, Institut Claudius Regaud, Cedex †Medical Oncology Department, Villejuif §Medical Oncology Department, Centre Léon Bérard, Lyon ¶Medical Oncology Department, Institut Paoli Calmette, Marseille, France.

View Article and Find Full Text PDF
November 2018

Ovarian Mucinous Cystadenoma After Ovarian Graft.

Obstet Gynecol 2017 06;129(6):1035-1036

Médecine de la Reproduction, CHU Toulouse, Institut universitaire du cancer de Toulouse, and Groupe de Recherche en Fertilité Humaine EA 3694, Université Paul Sabatier, Toulouse, France.

View Article and Find Full Text PDF
June 2017

Prediction of Everolimus Toxicity and Prognostic Value of Skeletal Muscle Index in Patients With Metastatic Renal Cell Carcinoma.

Clin Genitourin Cancer 2017 06 1;15(3):350-355. Epub 2017 Feb 1.

Oncology Department, European Georges Pompidou Hospital, René Descartes University, Paris, France; Association pour la Recherche sur les Thérapeutiques Innovantes en Cancérologie, Paris, France; U790 PARCC, European Georges Pompidou Hospital, René Descartes University, Paris, France. Electronic address:

View Article and Find Full Text PDF
June 2017

Development of Papulopustular Rosacea during Nivolumab Therapy for Metastatic Cancer.

Acta Derm Venereol 2017 04;97(4):539-540

Pulmonary Medicine Unit, Hôpital Larrey, Centre Hospitalier Universitaire Toulouse, , Université de Toulouse III,, 31 000 Toulouse, France.

View Article and Find Full Text PDF
April 2017

[Germ cell tumor in adolescents and young adults].

Bull Cancer 2016 Dec 4;103(12):1057-1063. Epub 2016 Nov 4.

Institut d'hémato-oncologie pédiatrique, 1, place J.-Renaud, 69008 Lyon, France. Electronic address:

View Article and Find Full Text PDF
December 2016

A Statistical Approach to Determine the Optimal Duration of Post-Treatment Follow-Up: Application to Metastatic Nonseminomatous Germ Cell Tumors.

Clin Genitourin Cancer 2017 04 8;15(2):230-236. Epub 2016 Aug 8.

Bureau des Essais Cliniques, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse - Oncopole, Toulouse, France. Electronic address:

View Article and Find Full Text PDF
April 2017

Zika virus in semen of a patient returning from a non-epidemic area.

Lancet Infect Dis 2016 08;16(8):894-5

Groupe de Recherche en Fertilité Humaine, Université de Toulouse, UPS, Toulouse, France; Centre d'Etudes et de Conservation des Oeufs et du Sperme, Centre Hospitalier Universitaire Paule de Viguier, Toulouse, France.

View Article and Find Full Text PDF
August 2016

Malignant Peripheral Nerve Sheath Tumor Is a Challenging Diagnosis: A Systematic Pathology Review, Immunohistochemistry, and Molecular Analysis in 160 Patients From the French Sarcoma Group Database.

Am J Surg Pathol 2016 07;40(7):896-908

Departments of *Pathology ‡Biostatistics **Oncology, Institut Claudius Regaud, IUCT-Oncopole, Toulouse †Department of Pathology, Centre Léon Bérard, Lyon §Department of Pathology, Centre Paul Papin, Angers ∥Department of Pathology, Centre Georges-Francois Leclerc, Dijon ¶Department of Pathology, Centre Oscar Lambret, Lille #Department of Pathology, Institut Gustave Roussy, Villejuif ††Department of Pathology and INSERM U916, Institut Bergonié ‡‡University Bordeaux Ségalen, Bordeaux, France.

View Article and Find Full Text PDF
July 2016

Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial.

J Clin Oncol 2015 Sep 27;33(25):2797-802. Epub 2015 Jul 27.

Isabelle L. Ray-Coquard, Philippe A. Cassier, and Jean-Yves Blay, Centre Léon Bérard and Claude Bernard University, Lyon; Julien Domont, Olivier Mir, and Axel Le Cesne, Gustave Roussy, Villejuif; Emmanuelle Tresch-Bruneel and Stéphanie Clisant, Centre Oscar Lambret; Nicolas Penel, Centre Oscar Lambret and Lille-Nord-de-France Medical School, Lille; Emmanuelle Bompas, Centre René Gauducheau, Nantes; Sophie Piperno-Neumann, Institut Curie, Paris; Antoine Italiano, Institut Bergonié, Bordeaux; Christine Chevreau, Institut Claudius Regaud, Toulouse; Didier Cupissol, Institut de Cancérologie de Montpellier, Val d'Aurelle, Montpellier; François Bertucci, Institut Paoli Calmette, Marseille; Jacques-Olivier Bay, Centre Jean Perrin, Clermont-Ferrand; Olivier Collard, Institut de Cancérologie de la Loire Lucien Neuwirth, Saint Priest en Jarez; Esma Saada-Bouzid, Centre Antoine Lacassagne, Nice; Nicolas Isambert, Centre Georges-François Leclerc, Dijon; and Corinne Delcambre, Centre François Baclesse, Caen, France.

View Article and Find Full Text PDF
September 2015

Randomized phase II study of nintedanib in metastatic castration-resistant prostate cancer postdocetaxel.

Anticancer Drugs 2014 Oct;25(9):1081-8

aDepartment of Medical Oncology, Centre Léon-Bérard, Claude Bernard Lyon-1 University, Lyon bMedical Oncology Department, Georges Pompidou European Hospital (HEGP), Paris cDepartment of Medical Oncology, Institut Claudius Regaud, Toulouse dBoehringer Ingelheim France S.A.S, Reims, France eBoehringer Ingelheim Pharma GmbH & Co. KG, Biberach, Germany.

View Article and Find Full Text PDF
October 2014

Abrupt development of Dupuytren's contractures with the BRAF inhibitor vemurafenib.

Joint Bone Spine 2014 Jul 24;81(4):373-4. Epub 2014 Jan 24.

Medical Oncology, Claudius Regaud Institute, Comprehensive Cancer Center, Toulouse, France.

View Article and Find Full Text PDF
July 2014

mTOR inhibitors in advanced renal cell carcinomas: from biology to clinical practice.

Crit Rev Oncol Hematol 2013 Oct 20;88(1):42-56. Epub 2013 Mar 20.

Department of Hematology and Oncology, Hôpital de Hautepierre, Avenue Molière, BP 49, 67098 Strasbourg Cedex, France. Electronic address:

View Article and Find Full Text PDF
October 2013

[Dermatologic side effects induced by new angiogenesis inhibitors].

Bull Cancer 2011 Oct;98(10):1221-9

Institut Claudius-Regaud, Toulouse cedex, France.

View Article and Find Full Text PDF
October 2011

[Managing side-effects of targeted therapies in renal cancer:surgical complications].

Bull Cancer 2011 ;98(3 Suppl):S61-7

CHU Lariboisière, chirurgie générale et viscérale, 2, rue Ambroise-Paré, 75475 Paris Cedex 10, France.

View Article and Find Full Text PDF
March 2015